Background Daily aspirin reduces the long-term risk of death due to cancer. However, the
short-term effect is less certain, especially in women, effects on cancer incidence are largely …

Respiratory tract infections may acutely increase risk from coronary heart disease (CHD),
though the mechanisms have not been defined. Patients with chronic obstructive pulmonary …

The proven benefit of aspirin in the secondary prevention of cardiovascular disease and its
possible value in primary prevention must be weighted against its potential hazards. This …

Abstract The Northwick Park Heart Study (NPHS) has investigated the thrombotic
component of ischaemic heart disease (IHD) by the inclusion of measures of haemostatic …

Background Treatment with daily aspirin for 5 years or longer reduces subsequent risk of
colorectal cancer. Several lines of evidence suggest that aspirin might also reduce risk of …

Background High-dose aspirin (≥ 500 mg daily) reduces long-term incidence of colorectal
cancer, but adverse effects might limit its potential for long-term prevention. The long-term …

The prevalence of urinary incontinence was investigated by determining the number of
incontinent patients under the care of various health and social service agencies in two …

The effects of respiratory viral infection on the time course of chronic obstructive pulmonary
disease (COPD) exacerbation were examined by monitoring changes in systemic …

Background Daily aspirin reduces the long-term incidence of some adenocarcinomas, but
effects on mortality due to some cancers appear after only a few years, suggesting that it …

Fibrinolytic activity (FA) was measured by dilute blood clot lysis time at entry to the Northwick
Park Heart Study in 1382 white men aged 40-64, of whom 179 subsequently experienced …